spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase PDB id
1gfw
Jmol
Contents
Protein chains
145 a.a. *
93 a.a. *
Ligands
MSI
Waters ×45
* Residue conservation analysis
PDB id:
1gfw
Name: Hydrolase
Title: The 2.8 angstrom crystal structure of caspase-3 (apopain or cpp32)in complex with an isatin sulfonamide inhibitor.
Structure: Caspase-3 (apopain, p20). Chain: a. Fragment: activated mature caspase-3 (p20) without pro- domain or linker (residues 29-175). Engineered: yes. Caspase-3 (apopain, p10). Chain: b. Fragment: activated mature caspase-3 (p10) without pro- domain or linker (residues 181-277).
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Other_details: human t-lymphocyte cell line jurkat.
Biol. unit: Octamer (from PQS)
Resolution:
2.80Å     R-factor:   0.200     R-free:   0.285
Authors: N.O.Concha,C.A.Janson
Key ref:
D.Lee et al. (2000). Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem, 275, 16007-16014. PubMed id: 10821855 DOI: 10.1074/jbc.275.21.16007
Date:
16-Jun-00     Release date:   23-Jun-00    
Supersedes: 1qa8
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P42574  (CASP3_HUMAN) -  Caspase-3
Seq:
Struc:
277 a.a.
145 a.a.
Protein chain
Pfam   ArchSchema ?
P42574  (CASP3_HUMAN) -  Caspase-3
Seq:
Struc:
277 a.a.
93 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: Chains A, B: E.C.3.4.22.56  - Caspase-3.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     cytoplasm   1 term 
  Biological process     apoptosis   2 terms 
  Biochemical function     cysteine-type peptidase activity     2 terms  

 

 
DOI no: 10.1074/jbc.275.21.16007 J Biol Chem 275:16007-16014 (2000)
PubMed id: 10821855  
 
 
Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality.
D.Lee, S.A.Long, J.L.Adams, G.Chan, K.S.Vaidya, T.A.Francis, K.Kikly, J.D.Winkler, C.M.Sung, C.Debouck, S.Richardson, M.A.Levy, W.E.DeWolf, P.M.Keller, T.Tomaszek, M.S.Head, M.D.Ryan, R.C.Haltiwanger, P.H.Liang, C.A.Janson, P.J.McDevitt, K.Johanson, N.O.Concha, W.Chan, S.S.Abdel-Meguid, A.M.Badger, M.W.Lark, D.P.Nadeau, L.J.Suva, M.Gowen, M.E.Nuttall.
 
  ABSTRACT  
 
Caspases have been strongly implicated to play an essential role in apoptosis. A critical question regarding the role(s) of these proteases is whether selective inhibition of an effector caspase(s) will prevent cell death. We have identified potent and selective non-peptide inhibitors of the effector caspases 3 and 7. The inhibition of apoptosis and maintenance of cell functionality with a caspase 3/7-selective inhibitor is demonstrated for the first time, and suggests that targeting these two caspases alone is sufficient for blocking apoptosis. Furthermore, an x-ray co-crystal structure of the complex between recombinant human caspase 3 and an isatin sulfonamide inhibitor has been solved to 2.8-A resolution. In contrast to previously reported peptide-based caspase inhibitors, the isatin sulfonamides derive their selectivity for caspases 3 and 7 by interacting primarily with the S(2) subsite, and do not bind in the caspase primary aspartic acid binding pocket (S(1)). These inhibitors blocked apoptosis in murine bone marrow neutrophils and human chondrocytes. Furthermore, in camptothecin-induced chondrocyte apoptosis, cell functionality as measured by type II collagen promoter activity is maintained, an activity considered essential for cartilage homeostasis. These data suggest that inhibiting chondrocyte cell death with a caspase 3/7-selective inhibitor may provide a novel therapeutic approach for the prevention and treatment of osteoarthritis, or other disease states characterized by excessive apoptosis.
 
  Selected figure(s)  
 
Figure 1.
Fig. 1. Caspase inhibitors.
Figure 2.
Fig. 2. A, 2F[o] F[c] electron density map. Stereo view of the final 2F[o] F[c] electron density map around the inhibitor and water molecule contoured at 1 level. The map was computed using data between 6.0 and 2.8 Å and model phases. A covalent bond links the inhibitor C-3 atom to Cys163S , the pyrrolidine ring binds in the S[2] binding pocket, and the phenoxy ring occupies the shallow S[3] binding site. In this complex the S[1] pocket is occupied by Wat518. The figure was prepared with BOBSCRIPT (47) and Raster3D. B, crystal structure of enzyme/inhibitor 4 complex. Stereo view of the molecular surface representation of the caspase 3 active site in complex with isatin sulfonamide 4. The catalytic residues His121 and Cys163 are colored by atom, the S[1] pocket is the unoccupied region behind the isatin ring (shown in black), and the hydrophobic S[2] pocket formed by Tyr204-Phe^256-Trp206 (left to right) is shown in magenta. Carbon atoms of inhibitor 4 are gray; oxygen atoms are red, nitrogen atom is blue, and sulfur atom is yellow. The figure was generated using the program MOLMOL (48).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2000, 275, 16007-16014) copyright 2000.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21337622 S.Y.Ponomarev, and J.Audie (2011).
Computational prediction and analysis of the DR6-NAPP interaction.
  Proteins, 79, 1376-1395.  
21441025 W.Chu, J.Rothfuss, D.Zhou, and R.H.Mach (2011).
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.
  Bioorg Med Chem Lett, 21, 2192-2197.  
20737104 Q.D.Nguyen, and E.O.Aboagye (2010).
Imaging the life and death of tumors in living subjects: Preclinical PET imaging of proliferation and apoptosis.
  Integr Biol (Camb), 2, 483-495.  
20589756 R.Roy, V.Kudryashov, I.Binderman, and A.L.Boskey (2010).
The role of apoptosis in mineralizing murine versus avian micromass culture systems.
  J Cell Biochem, 111, 653-658.  
20812287 S.Del Vecchio, A.Zannetti, R.Fonti, F.Iommelli, L.M.Pizzuti, A.Lettieri, and M.Salvatore (2010).
PET/CT in cancer research: from preclinical to clinical applications.
  Contrast Media Mol Imaging, 5, 190-200.  
19283487 B.Fang, G.Fu, J.Agniswamy, R.W.Harrison, and I.T.Weber (2009).
Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
  Apoptosis, 14, 741-752.
PDB codes: 3gjq 3gjr 3gjs 3gjt
19647171 D.L.Chen, D.Zhou, W.Chu, P.E.Herrbrich, L.A.Jones, J.M.Rothfuss, J.T.Engle, M.Geraci, M.J.Welch, and R.H.Mach (2009).
Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography.
  Nucl Med Biol, 36, 651-658.  
19300818 D.Zhou, W.Chu, D.L.Chen, Q.Wang, D.E.Reichert, J.Rothfuss, A.D'Avignon, M.J.Welch, and R.H.Mach (2009).
[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.
  Org Biomol Chem, 7, 1337-1348.  
18553063 K.McGonigal, J.Tanha, E.Palazov, S.Li, D.Gueorguieva-Owens, and S.Pandey (2009).
Isolation and functional characterization of single domain antibody modulators of Caspase-3 and apoptosis.
  Appl Biochem Biotechnol, 157, 226-236.  
19805307 Q.D.Nguyen, G.Smith, M.Glaser, M.Perumal, E.Arstad, and E.O.Aboagye (2009).
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide.
  Proc Natl Acad Sci U S A, 106, 16375-16380.  
19610597 Q.Wang, R.H.Mach, and D.E.Reichert (2009).
Docking and 3D-QSAR studies on isatin sulfonamide analogues as caspase-3 inhibitors.
  J Chem Inf Model, 49, 1963-1973.  
18768468 J.Q.Du, J.Wu, H.J.Zhang, Y.H.Zhang, B.Y.Qiu, F.Wu, Y.H.Chen, J.Y.Li, F.J.Nan, J.P.Ding, and J.Li (2008).
Isoquinoline-1,3,4-trione derivatives inactivate caspase-3 by generation of reactive oxygen species.
  J Biol Chem, 283, 30205-30215.
PDB codes: 3deh 3dei 3dej 3dek
16888817 E.P.Pourmand, I.Binderman, S.B.Doty, V.Kudryashov, and A.L.Boskey (2007).
Chondrocyte apoptosis is not essential for cartilage calcification: evidence from an in vitro avian model.
  J Cell Biochem, 100, 43-57.  
17464345 X.Q.Ma, H.J.Zhang, Y.H.Zhang, Y.H.Chen, F.Wu, J.Q.Du, H.P.Yu, Z.L.Zhou, J.Y.Li, F.J.Nan, and J.Li (2007).
Novel irreversible caspase-1 inhibitor attenuates the maturation of intracellular interleukin-1beta.
  Biochem Cell Biol, 85, 56-65.  
17032354 Y.H.Zhang, H.J.Zhang, F.Wu, Y.H.Chen, X.Q.Ma, J.Q.Du, Z.L.Zhou, J.Y.Li, F.J.Nan, and J.Li (2006).
Isoquinoline-1,3,4-trione and its derivatives attenuate beta-amyloid-induced apoptosis of neuronal cells.
  FEBS J, 273, 4842-4852.  
15956583 C.J.Lee, C.L.Liao, and Y.L.Lin (2005).
Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection.
  J Virol, 79, 8388-8399.  
15828017 K.M.Clements, N.Burton-Wurster, M.E.Nuttall, and G.Lust (2005).
Caspase-3/7 inhibition alters cell morphology in mitomycin-C treated chondrocytes.
  J Cell Physiol, 205, 133-140.  
15665817 U.Fischer, and K.Schulze-Osthoff (2005).
Apoptosis-based therapies and drug targets.
  Cell Death Differ, 12, 942-961.  
15693986 X.Zhang, Y.Chen, L.W.Jenkins, P.M.Kochanek, and R.S.Clark (2005).
Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury.
  Crit Care, 9, 66-75.  
14742529 A.Lührmann, N.Mauder, T.Sydor, E.Fernandez-Mora, J.Schulze-Luehrmann, S.Takai, and A.Haas (2004).
Necrotic death of Rhodococcus equi-infected macrophages is regulated by virulence-associated plasmids.
  Infect Immun, 72, 853-862.  
15314233 J.A.Hardy, J.Lam, J.T.Nguyen, T.O'Brien, and J.A.Wells (2004).
Discovery of an allosteric site in the caspases.
  Proc Natl Acad Sci U S A, 101, 12461-12466.
PDB codes: 1shj 1shl
15099652 J.G.Costouros, A.C.Dang, and H.T.Kim (2004).
Comparison of chondrocyte apoptosis in vivo and in vitro following acute osteochondral injury.
  J Orthop Res, 22, 678-683.  
14656672 M.Y.Lo, and H.T.Kim (2004).
Chondrocyte apoptosis induced by collagen degradation: inhibition by caspase inhibitors and IGF-1.
  J Orthop Res, 22, 140-144.  
15304288 M.Y.Lo, and H.T.Kim (2004).
Chondrocyte apoptosis induced by hydrogen peroxide requires caspase activation but not mitochondrial pore transition.
  J Orthop Res, 22, 1120-1125.  
14744804 S.Toulmond, K.Tang, Y.Bureau, H.Ashdown, S.Degen, R.O'Donnell, J.Tam, Y.Han, J.Colucci, A.Giroux, Y.Zhu, M.Boucher, B.Pikounis, S.Xanthoudakis, S.Roy, M.Rigby, R.Zamboni, G.S.Robertson, G.Y.Ng, D.W.Nicholson, and J.P.Flückiger (2004).
Neuroprotective effects of M826, a reversible caspase-3 inhibitor, in the rat malonate model of Huntington's disease.
  Br J Pharmacol, 141, 689-697.  
12563278 D.A.Erlanson, J.W.Lam, C.Wiesmann, T.N.Luong, R.L.Simmons, W.L.DeLano, I.C.Choong, M.T.Burdett, W.M.Flanagan, D.Lee, E.M.Gordon, and T.O'Brien (2003).
In situ assembly of enzyme inhibitors using extended tethering.
  Nat Biotechnol, 21, 308-314.
PDB codes: 1nme 1nmq 1nms
12833545 M.Sulpizi, A.Laio, J.VandeVondele, A.Cattaneo, U.Rothlisberger, and P.Carloni (2003).
Reaction mechanism of caspases: insights from QM/MM Car-Parrinello simulations.
  Proteins, 52, 212-224.  
12668429 M.Sulpizi, U.Rothlisberger, and P.Carloni (2003).
Molecular dynamics studies of caspase-3.
  Biophys J, 84, 2207-2215.  
12970077 W.Yang, J.Guastella, J.C.Huang, Y.Wang, L.Zhang, D.Xue, M.Tran, R.Woodward, S.Kasibhatla, B.Tseng, J.Drewe, and S.X.Cai (2003).
MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity.
  Br J Pharmacol, 140, 402-412.  
11996647 B.Swynghedauw (2002).
Myocardial remodelling: pharmacological targets.
  Expert Opin Investig Drugs, 11, 661-674.  
11981260 R.Bonegio, and W.Lieberthal (2002).
Role of apoptosis in the pathogenesis of acute renal failure.
  Curr Opin Nephrol Hypertens, 11, 301-308.  
11432986 A.Mora, G.Sabio, R.A.González-Polo, A.Cuenda, D.R.Alessi, J.C.Alonso, J.M.Fuentes, G.Soler, and F.Centeno (2001).
Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+ deprivation in cerebellar granule cells.
  J Neurochem, 78, 199-206.  
11406587 E.Sharif-Askari, A.Alam, E.Rhéaume, P.J.Beresford, C.Scotto, K.Sharma, D.Lee, W.E.DeWolf, M.E.Nuttall, J.Lieberman, and R.P.Sékaly (2001).
Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation.
  EMBO J, 20, 3101-3113.  
15989498 J.J.Legos, D.Lee, and J.A.Erhardt (2001).
Caspase inhibitors as neuroprotective agents.
  Expert Opin Emerg Drugs, 6, 81-94.  
11290317 L.Goyal (2001).
Cell death inhibition: keeping caspases in check.
  Cell, 104, 805-808.  
11728217 M.B.Goldring (2001).
Anticytokine therapy for osteoarthritis.
  Expert Opin Biol Ther, 1, 817-829.  
11166256 M.E.Nuttall, D.Lee, B.McLaughlin, and J.A.Erhardt (2001).
Selective inhibitors of apoptotic caspases: implications for novel therapeutic strategies.
  Drug Discov Today, 6, 85-91.  
11114501 M.G.Grütter (2000).
Caspases: key players in programmed cell death.
  Curr Opin Struct Biol, 10, 649-655.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.